Insider trade

Officer received an award of 49K EW derivative securities

Traded May 7, 2026 · Filed May 9, 2026

Edwards LifesciencesEW

49K
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 7, 2026
Reporting period: Not applicable
Filed with the SEC: May 9, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001225208-26-005043
Filed / recorded

May 9, 2026, 1:16 AM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

Edwards Lifesciences Corp

Issuer CIK

1099800

Ticker

EW

Reporting person

Daveen Chopra

Relationship

Officer

Officer title

CVP, TMTT & Surgical

Security

Employee Stock Option (Right to Acquire)

Table

Derivative (Table II)

Transaction date

May 7, 2026

Transaction code

A

Shares / units

49,100

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

49,100

Ownership form

Direct

Amendment

No

Footnotes from the filing

These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.